Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack F Shern

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Nature Communications|February 16, 2020
CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOGZhihui Liu, Xiyuan Zhang, Haiyan Lei, et al.
Oncogenesis|April 24, 2025
MYCN and KAT2A form a feedforward loop to drive an oncogenic transcriptional program in neuroblastomaZhihui Liu, Jason J Hong, Xiyuan Zhang, et al.
Endocrine-Related Cancer|December 11, 2025
The Prostate is a Common Site of Disease in Patients with MEN2B and Medullary Thyroid CarcinomaIra L Kraft, Srivandana Akshintala, Andrea Gross, et al.
Scientific Reports|July 25, 2020
Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children's Oncology GroupPooja Hingorani, Valentin Dinu, Xiyuan Zhang, et al.
The EMBO Journal|August 22, 2024
Targeting SWI/SNF ATPases reduces neuroblastoma cell plasticityMan Xu, Jason J Hong, Xiyuan Zhang, et al.
Cancer Immunology Research|June 26, 2025
GPC2-Targeted CAR T Cells Engineered with NFAT-Inducible Membrane-Tethered IL15/IL21 Exhibit Enhanced Activity against NeuroblastomaReona Okada, Jeyshka M Reyes-González, Constanza Rodriguez, et al.
Nature Communications|July 10, 2019
Chemical genomics reveals histone deacetylases are required for core regulatory transcriptionBerkley E Gryder, Lei Wu, Girma M Woldemichael, et al.
Cell Reports|September 21, 2022
Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumorXiyuan Zhang, Hannah E Lou, Vishaka Gopalan, et al.
Oncotarget|October 4, 2017
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcomaNarendra Bharathy, Matthew N Svalina, Teagan P Settelmeyer, et al.
Haematologica|February 9, 2018
Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphomaHaneen Shalabi, Ira L Kraft, Hao-Wei Wang, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Nature Communications|February 16, 2020
CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOGZhihui Liu, Xiyuan Zhang, Haiyan Lei, et al.
Oncogenesis|April 24, 2025
MYCN and KAT2A form a feedforward loop to drive an oncogenic transcriptional program in neuroblastomaZhihui Liu, Jason J Hong, Xiyuan Zhang, et al.
Endocrine-Related Cancer|December 11, 2025
The Prostate is a Common Site of Disease in Patients with MEN2B and Medullary Thyroid CarcinomaIra L Kraft, Srivandana Akshintala, Andrea Gross, et al.
Scientific Reports|July 25, 2020
Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children's Oncology GroupPooja Hingorani, Valentin Dinu, Xiyuan Zhang, et al.
The EMBO Journal|August 22, 2024
Targeting SWI/SNF ATPases reduces neuroblastoma cell plasticityMan Xu, Jason J Hong, Xiyuan Zhang, et al.
Cancer Immunology Research|June 26, 2025
GPC2-Targeted CAR T Cells Engineered with NFAT-Inducible Membrane-Tethered IL15/IL21 Exhibit Enhanced Activity against NeuroblastomaReona Okada, Jeyshka M Reyes-González, Constanza Rodriguez, et al.
Nature Communications|July 10, 2019
Chemical genomics reveals histone deacetylases are required for core regulatory transcriptionBerkley E Gryder, Lei Wu, Girma M Woldemichael, et al.
Cell Reports|September 21, 2022
Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumorXiyuan Zhang, Hannah E Lou, Vishaka Gopalan, et al.
Oncotarget|October 4, 2017
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcomaNarendra Bharathy, Matthew N Svalina, Teagan P Settelmeyer, et al.
Haematologica|February 9, 2018
Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphomaHaneen Shalabi, Ira L Kraft, Hao-Wei Wang, et al.
Pageof 10